Neurocrine Biosciences Inc
NBIX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000914475
In the last 90 days, Neurocrine Biosciences Inc insiders filed 0 open-market purchases and 7 sales; 782 institutions reported holding it in 13F filings for Q2 2026, worth $17.0B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Neurocrine Biosciences Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 7 filings
- 6 insiders, $6.24M in total
- Insiders trading
- 6
- Net value
- −$6.24M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Neurocrine Biosciences Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Onyia Jude | Chief Scientific Officer | 22,647 | Sep 15, 2026 | 9 |
| Lippoldt Darin | Chief Legal Officer | 56,793 | Sep 15, 2026 | 7 |
| Keswani Sanjay Chandru | Chief Medical Officer | 3,281 | Sep 15, 2026 | 3 |
| Gorman Kevin Charles | Director | 517,797 | Sep 15, 2026 | 5 |
| Gano Kyle | Chief Executive Officer | 154,728 | Sep 15, 2026 | 5 |
| Delaet Ingrid | Chief Regulatory Officer | 18,289 | Sep 15, 2026 | 6 |
| Cooke Julie | Chief Human Resources Officer | 24,025 | Sep 15, 2026 | 4 |
| Boyer David W. | Chief Corp. Affairs Officer | 8,722 | Sep 15, 2026 | 4 |
| Benevich Eric | Chief Commercial Officer | 67,297 | Sep 15, 2026 | 5 |
| Abernethy Matt | Chief Financial Officer | 42,808 | Sep 15, 2026 | 4 |
| Sherwin Stephen A | Director | 14,860 | Sep 3, 2026 | 4 |
| Norwalk Leslie V | Director | 2,430 | Jul 30, 2026 | 6 |
| Morrow George J | Director | 10,386 | May 29, 2026 | 3 |
| Lyons Gary A | Director | 122,141 | May 29, 2026 | 3 |
| Pops Richard F | Director | 37,798 | May 29, 2026 | 3 |
| Poon Christine A | Director | 4,753 | May 29, 2026 | 2 |
| Rastetter William H | Director | 43,678 | May 29, 2026 | 3 |
| Sharp Shalini | Director | 4,088 | May 29, 2026 | 2 |
| Mercier Johanna | Director | 6,853 | May 29, 2026 | 2 |
| Roberts Eiry | Chief Medical Officer | 35,640 | Feb 14, 2025 | 0 |
| Lloyd-Smith Malcolm | Chief Integration Officer | 42,337 | Feb 8, 2023 | 0 |
| Grigoriadis Dimitri E. | Chief Research Officer | 82,273 | Feb 2, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2022 (view filing) | Oct 26-27 | 2 days | Lippoldt DarinChief Legal Officer | SSale | −10.0K | $115.03 | −$1.15M | −25.5%29.2K after | 2 lots |
| Oct 19, 2022 (view filing) | Oct 17 | 2 days | Benevich EricChief Commercial Officer | SSale | −4.96K | $110.82 | −$549.7K | −24.1%15.6K after | |
| Oct 5, 2022 (view filing) | Oct 3 | 2 days | Boyer David W.Chief Corp. Affairs Officer | SSale | −1.44K | $106.59 | −$153.2K | −25.4%4.21K after | |
| Oct 5, 2022 (view filing) | Oct 4 | 1 day | Lyons Gary ADirector | SSale | −5.00K | $110.54 | −$552.7K | −2.4%203.7K after | |
| Oct 5, 2022 (view filing) | Oct 4 | 1 day | Lippoldt DarinChief Legal Officer | SSale | −10.0K | $111.04 | −$1.11M | −25.5%29.2K after | |
| Aug 16, 2022 (view filing) | Aug 12 | 4 days | Lloyd-Smith MalcolmChief Regulatory Officer | SSale | −21.5K | $105.95 | −$2.28M | −53.3%18.9K after | |
| Aug 9, 2022 (view filing) | Aug 5 | 4 days | Cooke JulieChief Human Resources Officer | SSale | −1.82K | $100.00 | −$181.6K | −10.7%15.1K after | |
| Jun 29, 2022 (view filing) | Jun 27 | 2 days | Cooke JulieChief Human Resources Officer | SSale | −754 | $100.00 | −$75.4K | −4.3%16.9K after | |
| May 11, 2022 (view filing) | May 9 | 2 days | Pops Richard FDirector | SSale | −15.0K | $76.30 | −$1.14M | −33.7%29.5K after | 2 lots |
| Apr 27, 2022 (view filing) | Apr 25 | 2 days | Lyons Gary ADirector | SSale | −15.0K | $92.76 | −$1.39M | −6.7%208.7K after | |
| Apr 5, 2022 (view filing) | Apr 1 | 4 days | Rastetter William HDirector | SSale | −10.7K | $94.93 | −$1.02M | −24.0%34.0K after | |
| Mar 22, 2022 (view filing) | Mar 18-22 | 4 days | Lippoldt DarinChief Legal Officer | SSale | −8.76K | $95.05 | −$832.1K | −22.9%29.4K after | 2 lots |
| Feb 9, 2022 (view filing) | Feb 7-8 | 2 days | Boyer David W.Chief Corp. Affairs Officer | SSale | −940 | $79.99 | −$75.2K | −24.4%2.92K after | 2 lots |
| Feb 9, 2022 (view filing) | Feb 7-8 | 2 days | Roberts EiryChief Medical Officer | SSale | −3.72K | $80.45 | −$299.6K | −13.1%24.6K after | 3 lots |
| Feb 9, 2022 (view filing) | Feb 7-8 | 2 days | Lloyd-Smith MalcolmChief Regulatory Officer | SSale | −3.38K | $80.48 | −$272.2K | −15.3%18.7K after | 4 lots |
| Feb 9, 2022 (view filing) | Feb 7-8 | 2 days | Lippoldt DarinChief Legal Officer | SSale | −4.08K | $80.45 | −$328.2K | −9.7%38.1K after | 4 lots |
| Feb 9, 2022 (view filing) | Feb 7-8 | 2 days | Gorman Kevin CharlesChief Executive Officer | SSale | −11.0K | $80.54 | −$884.7K | −2.3%462.8K after | 4 lots |
| Feb 9, 2022 (view filing) | Feb 7-8 | 2 days | Gano KyleChief Business Development Off | SSale | −6.88K | $80.62 | −$554.6K | −5.8%111.2K after | 5 lots |
| Feb 9, 2022 (view filing) | Feb 7-8 | 2 days | Cooke JulieChief Human Resources Officer | SSale | −2.86K | $80.38 | −$229.7K | −14.1%17.4K after | 4 lots |
| Feb 9, 2022 (view filing) | Feb 7-8 | 2 days | Benevich EricChief Commercial Officer | SSale | −5.10K | $80.57 | −$410.8K | −20.0%20.3K after | 4 lots |
| Feb 9, 2022 (view filing) | Feb 7-8 | 2 days | Abernethy MattChief Financial Officer | SSale | −4.29K | $80.53 | −$345.5K | −17.5%20.2K after | 3 lots |
| Jan 26, 2022 (view filing) | Jan 24 | 2 days | Sherwin Stephen ADirector | SSale | −15.0K | $74.43 | −$1.12M | −37.4%25.1K after | |
| Jan 12, 2022 (view filing) | Jan 10 | 2 days | Roberts EiryChief Medical Officer | SSale | −2.63K | $74.50 | −$196.1K | −11.0%21.3K after | |
| Jan 7, 2022 (view filing) | Jan 5 | 2 days | Gano KyleChief Business Development Off | SSale | −28.3K | $85.50 | −$2.42M | −21.2%105.0K after | |
| Dec 3, 2021 (view filing) | Dec 1 | 2 days | Abernethy MattChief Financial Officer | SSale | −1.65K | $82.59 | −$135.9K | −9.1%16.3K after | |
| Oct 12, 2021 (view filing) | Oct 7 | 5 days | Lyons Gary ADirector | SSale | −5.00K | $105.06 | −$525.3K | −2.3%208.7K after | |
| Oct 12, 2021 (view filing) | Oct 7 | 5 days | Grigoriadis Dimitri E.Chief Research Officer | SSale | −8.00K | $104.81 | −$838.5K | −8.9%82.3K after | 2 lots |
| Oct 6, 2021 (view filing) | Oct 4 | 2 days | Cooke JulieChief Human Resources Officer | SSale | −987 | $101.73 | −$100.4K | −6.2%14.8K after | |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Benevich EricChief Commercial Officer | SSale | −5.63K | $89.62 | −$504.4K | −26.5%15.6K after | |
| Jul 29, 2021 (view filing) | Jul 27 | 2 days | Lloyd-Smith MalcolmChief Regulatory Officer | SSale | −16.7K | $93.80 | −$1.57M | −51.4%15.8K after |